Gapping down
In reaction to disappointing earnings/guidance: SHLM -2.9%, ABGB -2.8%, AZZ -2.1%
Select metals/mining stocks trading lower: AG -3.5%, SSRI -2.8%, GFI -1.6%, ABX -1.3%
Other news: OCUL -33.3% (reported topline clinical data for its second Phase 3 clinical trial evaluating OTX-DP), HELI -12.8% announced tender offer to purchase up to $80 mln of its outstanding 9.375% senior notes due 2021), MX -8.3% (announced it received an expected notice of noncompliance with NYSE continued listing requirements due to failure to file Form 10-K), GEL -5.9% (announces pricing of 4 mln unit public offering at $44.42/unit), VLTC -5% (modest pullback after yday's advance), FCH -4% (announced that it is commencing a public offering of 14.5 mln shares of its common stock; reported Q1 RevPAR grew 13.1% yoy to $132.9), WBAI -3.6% (issued clarifiaction on announcement regarding online lottery sales in China; believes approval to provide online lottery sales in China is valid and has not been revoked or amended), DYAX -2.8% (announced proposed 7 mln share public offering of common stock), NBG -2.3% (cont uncertainty surrounding Greece), NRZ -2.1% (announced public offering of 40 mln shares of common stock; ~28.3 mln shares being offered by Home Loan Servicing Solutions (HLSS), remainder being sold by the company), GM -2.1% (Government of Canada announced the divestiture of its remaining shares in GM), HPP -1.6% (announces the pricing of an underwritten public offering of 5.25 mln shares of its common stock by selling stockholders), VIAB -1.6% (details strategic realignment), CERU -1.5% (priced its underwritten public offering of 5.84 mln shares of its common stock at a public offering price of $6.00 per share)
Analyst comments: UBNT -2.9% (downgraded to Underperform at BofA/Merrill), AXP -1.3% (downgraded to Underperform from Perform at Oppenheimer), TM -0.9% (downgraded to Neutral from Buy at UBS
)
In reaction to disappointing earnings/guidance: SHLM -2.9%, ABGB -2.8%, AZZ -2.1%
Select metals/mining stocks trading lower: AG -3.5%, SSRI -2.8%, GFI -1.6%, ABX -1.3%
Other news: OCUL -33.3% (reported topline clinical data for its second Phase 3 clinical trial evaluating OTX-DP), HELI -12.8% announced tender offer to purchase up to $80 mln of its outstanding 9.375% senior notes due 2021), MX -8.3% (announced it received an expected notice of noncompliance with NYSE continued listing requirements due to failure to file Form 10-K), GEL -5.9% (announces pricing of 4 mln unit public offering at $44.42/unit), VLTC -5% (modest pullback after yday's advance), FCH -4% (announced that it is commencing a public offering of 14.5 mln shares of its common stock; reported Q1 RevPAR grew 13.1% yoy to $132.9), WBAI -3.6% (issued clarifiaction on announcement regarding online lottery sales in China; believes approval to provide online lottery sales in China is valid and has not been revoked or amended), DYAX -2.8% (announced proposed 7 mln share public offering of common stock), NBG -2.3% (cont uncertainty surrounding Greece), NRZ -2.1% (announced public offering of 40 mln shares of common stock; ~28.3 mln shares being offered by Home Loan Servicing Solutions (HLSS), remainder being sold by the company), GM -2.1% (Government of Canada announced the divestiture of its remaining shares in GM), HPP -1.6% (announces the pricing of an underwritten public offering of 5.25 mln shares of its common stock by selling stockholders), VIAB -1.6% (details strategic realignment), CERU -1.5% (priced its underwritten public offering of 5.84 mln shares of its common stock at a public offering price of $6.00 per share)
Analyst comments: UBNT -2.9% (downgraded to Underperform at BofA/Merrill), AXP -1.3% (downgraded to Underperform from Perform at Oppenheimer), TM -0.9% (downgraded to Neutral from Buy at UBS
)